Teladoc Health reports Q2 revenue $592M (+18% YoY) but net loss $3.1B on $3.0B goodwill impairment

Teladoc Health, Inc.

2022-Q2 EPS reported -$60.72 revenue$1,157,729,000

Revenue $592.4M (+18% YoY); net loss per share $19.22, mainly from $3.0B non-cash goodwill impairment.
Adjusted EBITDA $46.7M, down 30% YoY from $66.8M.
CEO Jason Gorevic cited solid results and Primary360 momentum but noted macroeconomic uncertainty.
Six-month revenue $1.16B (+21% YoY); net loss $9.78B.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.